RESPIRATORY SYNCYTIAL VIRUS (RSV)
Clinical trials for RESPIRATORY SYNCYTIAL VIRUS (RSV) explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY SYNCYTIAL VIRUS (RSV) trials appear
Sign up with your email to follow new studies for RESPIRATORY SYNCYTIAL VIRUS (RSV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Two shots, one visit: trial tests combined vaccines for seniors
⭐️ VACCINE ⭐️ CompletedThis study aimed to see if it's safe and effective to give two important vaccines—one for RSV (a respiratory virus) and one for shingles—at the same time to adults aged 50 and older. Researchers enrolled 526 participants to check for side effects and measure the body's immune res…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 03, 2026 14:43 UTC
-
New RSV shot tested for easier storage and use
⭐️ VACCINE ⭐️ CompletedThis study tested the safety and immune response of an RSV vaccine packaged in multidose vials, which are easier to store and transport. It compared the multidose version, which contains a preservative, to the standard single-dose version without a preservative. The trial involve…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE3 • Sponsor: Pfizer • Aim: ⭐️ VACCINE ⭐️
Last updated Apr 02, 2026 14:56 UTC
-
Nursing home RSV vaccine study: does living situation affect protection?
⭐️ VACCINE ⭐️ CompletedThis study compared how well two already-approved RSV vaccines work in adults over 60. Researchers wanted to see if people living in nursing homes had a similar immune response to the vaccines as people of the same age living independently in the community. All 152 participants r…
Matched conditions: RESPIRATORY SYNCYTIAL VIRUS (RSV)
Phase: PHASE4 • Sponsor: University of Rochester • Aim: ⭐️ VACCINE ⭐️
Last updated Mar 31, 2026 12:12 UTC